These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 8683598

  • 1. Rearrangement of the former VL interface in the solution structure of a camelised, single antibody VH domain.
    Riechmann L.
    J Mol Biol; 1996 Jun 28; 259(5):957-69. PubMed ID: 8683598
    [Abstract] [Full Text] [Related]

  • 2. Conformations of the third hypervariable region in the VH domain of immunoglobulins.
    Morea V, Tramontano A, Rustici M, Chothia C, Lesk AM.
    J Mol Biol; 1998 Jan 16; 275(2):269-94. PubMed ID: 9466909
    [Abstract] [Full Text] [Related]

  • 3. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.
    Tan PH, Sandmaier BM, Stayton PS.
    Biophys J; 1998 Sep 16; 75(3):1473-82. PubMed ID: 9726949
    [Abstract] [Full Text] [Related]

  • 4. Functional mapping of conserved residues located at the VL and VH domain interface of a Fab.
    Chatellier J, Van Regenmortel MH, Vernet T, Altschuh D.
    J Mol Biol; 1996 Nov 22; 264(1):1-6. PubMed ID: 8950262
    [Abstract] [Full Text] [Related]

  • 5. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
    Chen Y, Stollar BD.
    J Immunol; 1999 Apr 15; 162(8):4663-70. PubMed ID: 10202006
    [Abstract] [Full Text] [Related]

  • 6. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability.
    Wörn A, Plückthun A.
    Biochemistry; 1998 Sep 22; 37(38):13120-7. PubMed ID: 9748318
    [Abstract] [Full Text] [Related]

  • 7. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
    van den Beucken T, van Neer N, Sablon E, Desmet J, Celis L, Hoogenboom HR, Hufton SE.
    J Mol Biol; 2001 Jul 13; 310(3):591-601. PubMed ID: 11439026
    [Abstract] [Full Text] [Related]

  • 8. An improved model of association for VH-VL immunoglobulin domains: asymmetries between VH and VL in the packing of some interface residues.
    Vargas-Madrazo E, Paz-García E.
    J Mol Recognit; 2003 Jul 13; 16(3):113-20. PubMed ID: 12833565
    [Abstract] [Full Text] [Related]

  • 9. Solution structure of an isolated antibody VL domain.
    Constantine KL, Friedrichs MS, Metzler WJ, Wittekind M, Hensley P, Mueller L.
    J Mol Biol; 1994 Feb 11; 236(1):310-27. PubMed ID: 8107112
    [Abstract] [Full Text] [Related]

  • 10. Crystallization of single-chain Fv proteins.
    Essig NZ, Wood JF, Howard AJ, Raag R, Whitlow M.
    J Mol Biol; 1993 Dec 05; 234(3):897-901. PubMed ID: 8254684
    [Abstract] [Full Text] [Related]

  • 11. Solution structure of a llama single-domain antibody with hydrophobic residues typical of the VH/VL interface.
    Vranken W, Tolkatchev D, Xu P, Tanha J, Chen Z, Narang S, Ni F.
    Biochemistry; 2002 Jul 09; 41(27):8570-9. PubMed ID: 12093273
    [Abstract] [Full Text] [Related]

  • 12. Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites.
    Kabat EA, Wu TT.
    J Immunol; 1991 Sep 01; 147(5):1709-19. PubMed ID: 1908882
    [Abstract] [Full Text] [Related]

  • 13. Domain interactions and antigen binding of recombinant anti-Z-DNA antibody variable domains. The role of heavy and light chains measured by surface plasmon resonance.
    Polymenis M, Stollar BD.
    J Immunol; 1995 Mar 01; 154(5):2198-208. PubMed ID: 7868893
    [Abstract] [Full Text] [Related]

  • 14. An autoantibody to single-stranded DNA: comparison of the three-dimensional structures of the unliganded Fab and a deoxynucleotide-Fab complex.
    Herron JN, He XM, Ballard DW, Blier PR, Pace PE, Bothwell AL, Voss EW, Edmundson AB.
    Proteins; 1991 Mar 01; 11(3):159-75. PubMed ID: 1749770
    [Abstract] [Full Text] [Related]

  • 15. Effects on interaction kinetics of mutations at the VH-VL interface of Fabs depend on the structural context.
    Khalifa MB, Weidenhaupt M, Choulier L, Chatellier J, Rauffer-Bruyère N, Altschuh D, Vernet T.
    J Mol Recognit; 2000 Mar 01; 13(3):127-39. PubMed ID: 10867708
    [Abstract] [Full Text] [Related]

  • 16. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
    Giles I, Lambrianides N, Latchman D, Chen P, Chukwuocha R, Isenberg D, Rahman A.
    Arthritis Res Ther; 2005 Mar 01; 7(1):R47-56. PubMed ID: 15642142
    [Abstract] [Full Text] [Related]

  • 17. Characterization of the backbone dynamics of an anti-digoxin antibody VL domain by inverse detected 1H-15N NMR: comparisons with X-ray data for the Fab.
    Constantine KL, Friedrichs MS, Goldfarb V, Jeffrey PD, Sheriff S, Mueller L.
    Proteins; 1993 Mar 01; 15(3):290-311. PubMed ID: 8456098
    [Abstract] [Full Text] [Related]

  • 18. Single domain antibodies: comparison of camel VH and camelised human VH domains.
    Riechmann L, Muyldermans S.
    J Immunol Methods; 1999 Dec 10; 231(1-2):25-38. PubMed ID: 10648925
    [Abstract] [Full Text] [Related]

  • 19. Conserved aromatic residues as determinants in the folding and assembly of immunoglobulin variable domains.
    Campion SR.
    Mol Immunol; 2016 Feb 10; 70():63-71. PubMed ID: 26742085
    [Abstract] [Full Text] [Related]

  • 20. The nature of antibody heavy chain residue H6 strongly influences the stability of a VH domain lacking the disulfide bridge.
    Langedijk AC, Honegger A, Maat J, Planta RJ, van Schaik RC, Plückthun A.
    J Mol Biol; 1998 Feb 10; 283(1):95-110. PubMed ID: 9761676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.